ArticleMedicine2026
Trends and disparities in gastrointestinal hemorrhage-related mortality in individuals with diabetes in the United States from 1999 to 2023: A cross-sectional study.
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Gastrointestinal hemorrhage in patients with diabetes is associated with a higher risk of death. This study examined the trends and disparities in U.S. adult mortality due to coexisting diabetes and gastrointestinal hemorrhage. We analyzed CDC WONDER data (1999-2023) for adults (≥25 years), where gastrointestinal hemorrhage and diabetes were listed together as underlying or contributory causes of death. Age-adjusted mortality rates (AAMRs) per 100,000 U.S. population were calculated, and trends in AAMRs were analyzed using Joinpoint regression software. Relevant sensitivity analyses were conducted to verify the direction of the overall trend. Sociodemographic and geographical disparities in relevant trends were also explored. From 1999 to 2023, gastrointestinal hemorrhage and diabetes mellitus concurrently led to 80,833 deaths among U.S. adults, at an AAMR of 1.45/100,000. There was no net change in mortality rates over this period (AAPC -0.16; 95% CI: -0.58-0.15). In contrast, the AAMRs from gastrointestinal hemorrhage without fatal diabetes decreased (AAPC -1.03; 95% CI: -1.56 to -0.52). Males exhibited higher mortality rates from coexisting gastrointestinal hemorrhage and diabetes (Males 1.84 vs Females 1.15). Non-Hispanic American Indian/Alaska Native (2.97) and NH Black/African American (2.32) populations had the highest AAMRs. Disproportionately high overall rates were observed in the West (1.53) and South (1.48) regions. Moreover, AAMRs were notably higher in rural areas (rural: 1.72 vs urban: 1.31). Further evidence is required to establish the bidirectional mortality risks associated with gastrointestinal hemorrhage in patients with diabetes. Nonetheless, the disproportionate and persistent mortality burden in the U.S. demands attention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.